These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34289335)

  • 1. Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021.
    Vignier N; Bérot V; Bonnave N; Peugny S; Ballet M; Jacoud E; Michaud C; Gaillet M; Djossou F; Blanchet D; Lavergne A; Demar M; Nacher M; Rousset D; Epelboin L
    Emerg Infect Dis; 2021 Oct; 27(10):2673-2676. PubMed ID: 34289335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illegal gold miners in French Guiana: a neglected population with poor health.
    Douine M; Mosnier E; Le Hingrat Q; Charpentier C; Corlin F; Hureau L; Adenis A; Lazrek Y; Niemetsky F; Aucouturier AL; Demar M; Musset L; Nacher M
    BMC Public Health; 2017 Jul; 18(1):23. PubMed ID: 28716015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey.
    Mathema B; Chen L; Wang P; Cunningham MH; Mediavilla JR; Chow KF; Luo Y; Zhao Y; Composto K; Zuckerman J; Zody MC; Wilson N; Lee A; Oschwald DM; Liu L; Iketani S; Germer S; Fennessey S; Wang M; Kramer Y; Toole P; Maniatis T; Ho DD; Perlin DS; Kreiswirth BN
    mBio; 2022 Oct; 13(5):e0214122. PubMed ID: 35997285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake.
    Tene Y; Levytskyi K; Adler A; Halutz O; Paran Y; Goldshmidt H; Itzhaki-Alfia A; Halperin T; Stepansky S; Ben-Ami R; Henig O
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):114-117. PubMed ID: 34538284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
    Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir.
    Douine M; Musset L; Corlin F; Pelleau S; Pasquier J; Mutricy L; Adenis A; Djossou F; Brousse P; Perotti F; Hiwat H; Vreden S; Demar M; Nacher M
    Malar J; 2016 Jun; 15():315. PubMed ID: 27277831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.
    Gharpure R; Sami S; Vostok J; Johnson H; Hall N; Foreman A; Sabo RT; Schubert PL; Shephard H; Brown VR; Brumfield B; Ricaldi JN; Conley AB; Zielinski L; Malec L; Newman AP; Chang M; Finn LE; Stainken C; Mangla AT; Eteme P; Wieck M; Green A; Edmundson A; Reichbind D; Brown V; Quiñones L; Longenberger A; Hess E; Gumke M; Manion A; Thomas H; Barrios CA; Koczwara A; Williams TW; Pearlowitz M; Assoumou M; Senisse Pajares AF; Dishman H; Schardin C; Wang X; Stephens K; Moss NS; Singh G; Feaster C; Webb LM; Krueger A; Dickerson K; Dewart C; Barbeau B; Salmanson A; Madoff LC; Villanueva JM; Brown CM; Laney AS
    Emerg Infect Dis; 2022 Jan; 28(1):35-43. PubMed ID: 34793690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.
    Strickler SS; Esper A; Wells L; Wood A; Frediani JK; Nehl E; Waggoner JJ; Rebolledo PA; Levy JM; Figueroa J; Ramachandra T; Lam W; Martin GS
    Front Med (Lausanne); 2022; 9():1031083. PubMed ID: 36507539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021.
    Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a possible malaria epidemic in an illegal gold mine in French Guiana: an original approach in the remote Amazonian forest.
    Douine M; Sanna A; Hiwat H; Briolant S; Nacher M; Belleoud D; Le Tourneau FM; Bogreau H; De Laval F
    Malar J; 2019 Mar; 18(1):91. PubMed ID: 30902054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.
    Lafuente-Lafuente C; Rainone A; Guérin O; Drunat O; Jeandel C; Hanon O; Belmin J;
    Gerontology; 2022; 68(12):1384-1392. PubMed ID: 35313315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
    Harris JR; Owusu D; O'Laughlin K; Cohen AL; Ben Hamida A; Patel JC; Freeman MM; Nsibambi T; Nieves R; Marston BJ; Wasike S; Galbraith JS; Boore AL; Nelson LJ; Guagliardo SAJ; Klena JD; Patel K; Ma M
    Emerg Infect Dis; 2022 Jun; 28(6):1279-1280. PubMed ID: 35470796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
    Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B;
    Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center.
    Jacobson KB; Pinsky BA; Montez Rath ME; Wang H; Miller JA; Skhiri M; Shepard J; Mathew R; Lee G; Bohman B; Parsonnet J; Holubar M
    Clin Infect Dis; 2022 Mar; 74(5):821-828. PubMed ID: 34137815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.
    Nicolete VC; Rodrigues PT; Fernandes ARJ; Corder RM; Tonini J; Buss LF; Sales FC; Faria NR; Sabino EC; Castro MC; Ferreira MU
    Emerg Infect Dis; 2022 Mar; 28(3):709-712. PubMed ID: 34963505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.